Company news
Novaccess Global Inc. (OTC:XSNX) news
Novaccess Global Inc. news releases on 6ix. Latest, May 21, 2024: NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine…
Press releases & updates
NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform
May 20, 2024
NovAccess Global Advisory on Annual Meeting of Shareholders
May 6, 2024
NovAccess Global Announces New License to Advance its Immunotherapy Platform
April 29, 2024
NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
February 29, 2024
NovAccess Global Announces $10.7 Million Financing
January 1, 2024
NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
November 9, 2023
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
July 26, 2023
NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day
July 12, 2023
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
June 15, 2023
NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies
May 31, 2023
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements
May 10, 2023
Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award
March 14, 2023
NovAccess Global to Present at World Orphan Drug Congress
February 15, 2023
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress
February 2, 2023
NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division
January 4, 2023
NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate
November 21, 2022
NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board
November 9, 2022
NovAccess Global Announces Virtual Annual Shareholders' Meeting
November 7, 2022
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1
October 25, 2022
NovAccess Global Announces Fireside Chat with Board Member Perspectives
October 19, 2022
NovAccess Global Announces Fireside Chat Series for the Investment Community
September 28, 2022
NovAccess Global Announces Effectiveness of Form S-1 Registration Statement
September 21, 2022
NovAccess Global Announces Uplisting to OTCQB
August 9, 2022
OTC Markets Group Welcomes New OTCQB Companies – August 8
August 8, 2022
CORRECTION: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
July 18, 2022
NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
July 18, 2022
NovAccess Global CEO Dwain Irvin Featured on MoneyTV
June 13, 2022